Product Information

EPLERENONE 25 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3621 per EA under NDC 59762110702. Its NADAC has been published 93 times since Feb 12, 2025.

FDA first approved this application on Sep 27, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the eplerenone market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

EPLERENONE 25 MG TABLET

eplerenone
$0.3621per EA
Low Outlier

Strength

25 mg/1

NDC

59762110702

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

EPLERENONE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021437

FDA Approved

9/27/2002

TE Code

AB

On Market Since

12/13/2024

Pharmacological Classes

Aldosterone Antagonist
Aldosterone Antagonists

Price Statistics

The NADAC for EPLERENONE 25 MG TABLET has been published 93 times since Feb 12, 2025, and over the history we have for it it has declined 8.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3621 per EA
All-time high$0.5027 (Jul 16, 2025)
All-time low$0.3001 (Jul 22, 2026)
52-week high$0.3825
52-week low$0.3001
Median price$0.3612
Average price$0.3913
Largest weekly change+17.7% (Feb 19, 2025)
Weeks tracked93
Tracking sinceFeb 12, 2025

Price History

1W

+9.3%

1M

+17.6%

3M

+18.6%

6M

+14.0%

1Y

-5.3%

3Y

N/A

5Y

N/A

All

-8.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EPLERENONE 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EPLERENONE 25 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3621 per EA (NDC 59762110702), effective Nov 18, 2026.

How has the price of EPLERENONE 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for EPLERENONE 25 MG TABLET has declined 8.1%. It has been tracked across 93 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for EPLERENONE 25 MG TABLET?

Since Feb 12, 2025, the NADAC for EPLERENONE 25 MG TABLET has ranged from a low of $0.3001 (Jul 22, 2026) to a high of $0.5027 (Jul 16, 2025), with a median of $0.3612 per EA.

Are there cheaper alternatives to EPLERENONE 25 MG TABLET?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPLERENONE 25 MG TABLET, is $0.3052 per EA — about 16% below EPLERENONE 25 MG TABLET.

Who manufactures EPLERENONE 25 MG TABLET?

EPLERENONE 25 MG TABLET (NDC 59762110702) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.